GT200600524A - Preparacion de gamma-aminoacidos que tienen afinidad por la proteina alfa-2-delta - Google Patents

Preparacion de gamma-aminoacidos que tienen afinidad por la proteina alfa-2-delta

Info

Publication number
GT200600524A
GT200600524A GT200600524A GT200600524A GT200600524A GT 200600524 A GT200600524 A GT 200600524A GT 200600524 A GT200600524 A GT 200600524A GT 200600524 A GT200600524 A GT 200600524A GT 200600524 A GT200600524 A GT 200600524A
Authority
GT
Guatemala
Prior art keywords
alfa
amino acids
gamma
affinity
preparation
Prior art date
Application number
GT200600524A
Other languages
English (en)
Inventor
Margaret Claire Evans
Lloyd Charles Franklin
Lorraine Michelle Murtagh
Thomas Norman Nanninga
Bruce Allen Pearlman
James Edward Saenz
Niamh Josephine Willis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GT200600524A publication Critical patent/GT200600524A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE TIENE UN PROCEDIMIENTO PARA PREPARAR GAMA AMINOÁCIDOS ÓPTICAMENTE ACTIVOS DE FÓRMULA 1, QUE PUEDEN SER UNA SAL DEL MISMO, PREFERIBLEMENTE UNA SAL DE METAL ALCALINO COMO EL SODIO. DICHOS COMPUESTOS SE UNEN A LA SUBUNIDAD ALFA-2-DELTA DE UN CANAL DE CALCIO.
GT200600524A 2005-12-21 2006-12-20 Preparacion de gamma-aminoacidos que tienen afinidad por la proteina alfa-2-delta GT200600524A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21

Publications (1)

Publication Number Publication Date
GT200600524A true GT200600524A (es) 2007-12-03

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600524A GT200600524A (es) 2005-12-21 2006-12-20 Preparacion de gamma-aminoacidos que tienen afinidad por la proteina alfa-2-delta

Country Status (28)

Country Link
US (2) US20070141684A1 (es)
EP (2) EP2017259A3 (es)
JP (1) JP2009520492A (es)
KR (1) KR20080068932A (es)
CN (1) CN101341117A (es)
AP (1) AP2008004485A0 (es)
AR (1) AR058559A1 (es)
AU (1) AU2006327872A1 (es)
BR (1) BRPI0620467A2 (es)
CA (1) CA2633358A1 (es)
CR (1) CR10080A (es)
DO (1) DOP2006000286A (es)
EA (1) EA200801393A1 (es)
EC (1) ECSP088551A (es)
GT (1) GT200600524A (es)
IL (1) IL191840A0 (es)
MA (1) MA30139B1 (es)
ME (1) ME00005B (es)
NL (1) NL2000374C2 (es)
NO (1) NO20082989L (es)
NZ (1) NZ568971A (es)
PE (1) PE20071169A1 (es)
RS (1) RS20080279A (es)
TN (1) TNSN08272A1 (es)
TW (1) TW200736201A (es)
UY (1) UY30031A1 (es)
WO (1) WO2007072159A1 (es)
ZA (1) ZA200804780B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110025917A (ko) * 2008-05-21 2011-03-14 산도즈 아게 ５－메틸－３－니트로메틸－헥산산 에스테르의 입체선택적 효소 가수분해 방법
WO2011144742A1 (en) 2010-05-21 2011-11-24 Chemilia Ab Novel pyrimidine derivatives
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
AU2012230229A1 (en) 2011-03-24 2013-10-10 Noviga Research Ab Novel pyrimidine derivatives
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (ja) * 2016-03-10 2017-09-14 第一三共株式会社 酵素による光学分割を用いた光学活性吉草酸誘導体の製造方法
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
TR200103587T2 (tr) 1999-06-10 2002-04-22 Warner Lambert Company Mono-ve çift ikame edilmiş 3-propil gama aminobutirik asitler.
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
CA2505788A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)

Also Published As

Publication number Publication date
UY30031A1 (es) 2007-07-31
NO20082989L (no) 2008-09-19
KR20080068932A (ko) 2008-07-24
EA200801393A1 (ru) 2009-12-30
EP2017259A3 (en) 2011-04-13
WO2007072159B1 (en) 2008-08-21
WO2007072159A1 (en) 2007-06-28
ME00005B (me) 2010-06-10
CR10080A (es) 2008-07-10
CN101341117A (zh) 2009-01-07
EP1973867A1 (en) 2008-10-01
IL191840A0 (en) 2008-12-29
NZ568971A (en) 2010-04-30
BRPI0620467A2 (pt) 2011-11-16
AP2008004485A0 (en) 2008-06-30
NL2000374C2 (nl) 2010-02-09
MEP0708A (xx) 2010-02-10
US20090299093A1 (en) 2009-12-03
PE20071169A1 (es) 2007-11-30
NL2000374A1 (nl) 2007-06-25
EP2017259A2 (en) 2009-01-21
MA30139B1 (fr) 2009-01-02
AU2006327872A1 (en) 2007-06-28
JP2009520492A (ja) 2009-05-28
AR058559A1 (es) 2008-02-13
US20070141684A1 (en) 2007-06-21
DOP2006000286A (es) 2007-07-31
TNSN08272A1 (fr) 2009-10-30
RS20080279A (en) 2009-07-15
ZA200804780B (en) 2009-05-27
TW200736201A (en) 2007-10-01
CA2633358A1 (en) 2007-06-28
ECSP088551A (es) 2008-07-30

Similar Documents

Publication Publication Date Title
GT200600524A (es) Preparacion de gamma-aminoacidos que tienen afinidad por la proteina alfa-2-delta
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
GT201100181A (es) "inhibidores de proteina cinasa"
UY32730A (es) Inhibidores de cyp17
CY1119730T1 (el) Παραγωγα καρβοξυλικου οξεος πυρρολιδινης ως αγωνιστες του συζευγμενου με πρωτεϊνή-g υποδοχεα 43 (gpr43), φαρμακευτικη συνθεση και μεθοδοι για χρηση στην αντιμετωπιση μεταβολικων διαταραχων
RS50720B (sr) 3,11 b-cis-dihidrotetrabenazin za lečenje proliferativne bolesti ili inflamacije
EA200970067A1 (ru) Агонисты ep2
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
CO6541569A2 (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
EA201592255A1 (ru) Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания
EA201001772A1 (ru) Производные 3,5-диамино-6-хлорпиразин-2-карбоновой кислоты и их применение в качестве блокаторов эпителиальных натриевых каналов для лечения заболеваний дыхательных путей
ES2563777T3 (es) Compuestos de nitrona para tratar la pérdida auditiva sensorineural
AR111570A1 (es) Composición farmacéutica que comprende selexipag
EA201290416A1 (ru) Новые спиропиперидиновые соединения
CR10794A (es) Composiciones de fenilalquilamino-carbamato
EA200970126A1 (ru) Способ получения прегабалина и его энантиомера
CR9993A (es) Formulación de suspensión de fexofenadina
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
ECSP088992A (es) Inhibidores de akt (proteina cinasa b)
EA201170483A1 (ru) Твердая фармацевтическая композиция
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
EA201300493A1 (ru) Гербицидная композиция
PE20151055A1 (es) Compuestos triciclicos para inhibir el canal cftr